Atopic Dermatitis for All Ages: A Simulation on Targeted Systemic Therapies

Overview

Provider Statement

This continuing education activity is provided by 

Support Statement

This activity is supported by an educational grant from Sanofi and Regeneron Pharmaceuticals.

Activity Description

Moderate-to-severe atopic dermatitis has profound negative impacts on patients and family quality of life (QoL). The burden of this condition encompasses personal, social, economic, academic, and occupational realms. However, treatment options for atopic dermatitis have evolved dramatically in the past several years. This simulation presents an authentic practice environment in which to implement guidelines and treatment strategies across an array of increasingly challenging clinical presentations. Participants are able to select a systemic therapy for moderate-to-severe atopic dermatitis based on data for safety, efficacy, and the ability to improve patient QoL in real-world practice. Atopic Dermatitis for All Ages demonstrates approaches to managing patients with moderate-to-severe atopic dermatitis based on patient needs, recent clinical evidence, and an interprofessional approach to comprehensive management and targeted treatment.

Target Audience

The intended audience for this activity is dermatologists, pediatricians, nurses, nurse practitioners, physician associates, and other healthcare professionals involved in the management of patients with atopic dermatitis.

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

• Recognize the physical and psychosocial burden of moderate-to-severe atopic dermatitis to better understand the need for interprofessional, comprehensive management and targeted treatments.
• Select a systemic therapy for moderate-to-severe atopic dermatitis based on data for safety, efficacy, and ability to improve patient quality of life in real-world practice.

Faculty

Mira Choi, MD
Visiting Physician
Rady Children's Hospital San Diego
San Diego, CA
Case 2

Lawrence F. Eichenfield, MD
Chief, Pediatric and Adolescent Dermatology
Professor of Dermatology and Pediatrics
Vice Chair, Department of Dermatology
University of California, San Diego School of Medicine
Rady Children’s Hospital San Diego
San Diego, CA
Case 1 and 2

Jonathan I. Silverberg, MD, PhD, MPH, FAAD
Professor
Director of Clinical Research
Director of Patch Testing
George Washington University School of Medicine and Health Sciences
Washington, DC
Case 3

Planners/Reviewers

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Barbara A. Niedz, PhD, RN, CPHQ

Accreditation

In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 1.50 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.

Vindico Medical Education designates this activity for 1.50 nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Upon successful completion, learners who opt in by providing their ABP ID and DOB (MM/DD) will earn MOC points equivalent to the amount of CME credits claimed for the activity.

This activity is approved for 1.5 contact hour(s) of continuing education (which includes 0.5 hour(s) of pharmacology) by the American Association of Nurse Practitioners®. Activity ID# 23106421. This activity was planned in accordance with AANP Accreditation Standards and Policies.

American Academy of Physician Associates (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit(s)™ from organizations accredited by ACCME. PAs may receive a maximum of 1.50 credit hours for completing this program.

This enduring material is approved for 1 year from the date of original release, October 31, 2023, to October 30, 2024.

How to Participate in This Activity and Obtain CE Credit

To participate in this activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 2 of the 3 posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate or Contact Hour Certificate.

Disclosures

Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Relationship information is accurate at the time of content development.

Faculty report the following relevant financial relationship(s)

Mira Choi, MD
No relevant financial relationships to disclose.

Lawrence F. Eichenfield, MD
Advisor: AbbVie, Arcutis, ASLAN, Bausch + Lomb, Forte, Incyte, Leo, Lilly, Pfizer, Regeneron, Sanofi
Consultant: AbbVie, Amgen, Amryt, Almirall, Arcutis, ASLAN, Bristol Myers Squibb, Dermata, Dermavant, Forte, Galderma, Incyte, Janssen, Krystal, Leo, Lilly, Novartis, Otsuka, Pfizer, Regeneron, Sanofi, UCB
Speaker Contracted by Ineligible Company: Incyte, Krystal, Leo, Pfizer, Regeneron, Sanofi
Independent Research Contractor (paid to institution): AbbVie, Arcutis, Bausch + Lomb, Dermavant, Galderma, Incyte, Pfizer

Jonathan I. Silverberg MD, PHD, MPH, FAAD
Consultant: AbbVie, Alamar, Aldena, Amgen, AOBiome, Arcutis, Arena, Asana, ASLAN, BiomX, Biosion, Bodewell, Boehringer Ingelheim, Bristol Myers Squibb, Cara Therapeutics, Celgene, Connect Biopharma, Dermavant, DermTech, Galderma, GSK, Incyte, Kiniksa, LEO Pharma, Lilly, Nektar, Novartis, Optum, Pfizer, RAPT Therapeutics, Recludix, Regeneron, Sanofi, Shaperon, UNION therapeutics
Speaker Contracted by Ineligible Company: AbbVie, LEO Pharma, Lilly, Pfizer, Regeneron, Sanofi
Independent Research Contractor (paid to institution): Galderma, Incyte, Pfizer
Individual Stocks and Stock Options: Lilly

Planners/Reviewers reports the following relevant financial relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Barbara A. Niedz, PhD, RN, CPHQ
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relevant financial relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage

The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2023 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CE Questions?

Contact us at cme@vindicoCME.com